Navigation Links
Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014
Date:8/1/2014

Stony Brook, NY (PRWEB) August 01, 2014

Applied DNA Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, will host a conference call on Tuesday August 12, 2014 to discuss its fiscal third quarter results. The Quarterly Report on Form 10Q will be filed with the SEC by the end of the day on Monday August 11, 2014.

Applied DNA Sciences, Inc. management will host a conference call beginning at 9:00 A.M. Eastern Daylight Time on Tuesday August 12, 2014 to discuss the company’s performance and outline key ongoing and future business initiatives. A presentation by President and CEO Dr. James Hayward and CFO Karol Kain Gray will be followed by a question-and-answer session.

All participants must pre-register using the link below. It is suggested that you log into the conference call approximately 10 minutes prior to the scheduled start time to ensure that all participants are on-line at the start of the call. While callers cannot be heard during the call, questions may be emailed beforehand to investor(at)adnas(dot)com

To Participate:
Reserve your Webinar seat now at: https://www3.gotomeeting.com/register/516127918

To send questions prior to the call:
Please email questions prior to the call to investor(at)adnas(dot)com
While every attempt will be made to answer your questions, due to the large number of expected participants, not all questions may be answered on the call.

For those of you unable to participate, a transcript of the call will be posted by end of business on August 12, 2014, and available under the “Investors” tab of the company’s web site.

Company Background Materials:
You may be interested in the company’s Investor Information section on the company’s website, including publications, recent press releases, blogs, and other materials.
http://www.adnas.com/investors/investor-kit

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the uncopyable marker that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 20, 2013 (amended on May 1, 2014) and our subsequent quarterly reports on Form 10-Q/A (for the quarterly period ended December 31, 2013) and Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12066146.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences
2. CAP Technology is Being Applied to Isolation/Containment Applications Worldwide
3. Applied Silicone Launches Ultra-Soft LSR
4. Pittcon Recognizes Outstanding Achievements in Analytical Chemistry and Applied Spectroscopy
5. Dr. Rongxiang Xu: Mankind Is Entering New Era of Applied Organ Regeneration Science
6. Applied Integrin Sciences, Inc. Announces Exceptional Results In Ovarian Cancer Study
7. Best papers in applied technology from Springer journals chosen
8. SPIE Appoints Ni-Bin Chang Editor of Journal of Applied Remote Sensing
9. SPIE Encouraged By Increased Science Funding in Obama Budget, Urges Applied Research Emphasis
10. APPLIED PHYSIOLOGY® Receives key US Patent Award for its Unique NAVIGATOR™ Technology
11. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, ... ... of advanced software solutions for pharmaceutical research and development (R&D), today announced ... in omic data analysis and interpretation for the rapidly evolving field of ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, ... Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious ... agreement for the merger of PharmAthene and Altimmune ... Novartis Venture Fund, HealthCap, Truffle Capital and Redmont ... and diversified immunotherapeutics company with four clinical stage ...
(Date:1/19/2017)... 19, 2017 AquaBounty Technologies, Inc. (AIM: ABTU; ... in aquaculture and a majority-owned subsidiary of Intrexon Corporation ... completed the listing of its common shares on the ... Intrexon. "AquaBounty,s listing on NASDAQ represents an ... exposure to the U.S. markets as we advance plans ...
(Date:1/19/2017)... ... January 18, 2017 , ... ... innovators, engineers, and scientists from around the world, was today awarded the "Best ... program is based entirely on merit and decided upon by a dedicated team ...
Breaking Biology Technology:
(Date:1/3/2017)... Onitor, provider of digital health technology for ... innovative biometric data-driven program designed to aid weight loss ... 2017 Consumer Electronics Show (CES) in Las ... the World Health Organization (WHO), have identified lifestyle risks ... are overweight or obese. WHO also states that more ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016 /PRNewswire/ ... que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que ... de tumor en 2017, con múltiples sitios previstos a lo largo ... ... en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
Breaking Biology News(10 mins):